Being a key supplier to end industries which are essential in nature, Balaji Amines Limited do not foresee a major impact on revenue and profitability during these times.

 

The company kept all the plants partially running despite the lockdown as it is a supplier to the essential industry of pharmaceuticals and healthcare. The company has been operating all plants with standard operating procedures with high levels of safety protocols.

 

The capacity utilization of the plants has been affected due to various factors like unavailability of labour, disrupted supplies of packing material, delays in port clearances, limited availability of trucks and tankers for movement of raw material and finished goods. As lockdown eases we are confident to ramp up capacity utilization levels.

 

Currently, the company has enough liquidity to continue its operations and does not expect any liquidity crunch. The company has resources to service the debt and other ongoing projects. The company is paying its lenders as per due date and has not availed any moratorium.

 

The business processes were carried out normally and during the lockdown period; businesses were transacted as per internal finance control system in place. Though the distribution & supply chain network has been partially impacted, the company is ensuring the movement of products to the consumers as per government guidelines. 

 

Demand for our products in domestic as well as in international market is adequate and we see no major impact going forward.

 

The proposed new project of Unit IV which is coming up in 90 acres at MIDC, Chincholi is under progress and there are some long delivery suppliers of equipment who have intimated that they may require some extended time for delivery. This may impact the timelines of trial production.